Cell Kinetic and Cytological Grading of Prostatic Carcinoma

Overview

Journal Virchows Arch A Pathol Anat Histol

Specialty Pathology

Date 1981 Jan 1

PMID 7292980

Citations 2

Authors

B Helpap

Affiliations

Soon will be listed here.

Abstract

In 69 cases of prostatic carcinomas The 3H-thymidine labelling index was studied, and a cytological analysis was performed in addition to the histological classification. The following cytological variables were measured: nuclear size and shape, nuclear-cytoplasmic-ratio, nuclear chromasia, size and form of nucleoli. Only prostatic carcinomas with a labelling index of less than 0.4% showed mild nuclear anaplasia. These carcinomas were histologically classified as well differentiated adenocarcinomas. Prostatic carcinomas with a labelling index from 0.4% to 1.0% showed moderate nuclear anaplasia. These carcinomas were poorly differentiated adenocarcinomas. Carcinomas with labeling indices between 1.4 and 2.3% had moderate - marked nuclear anaplasia and exhibited a transition to undifferentiated carcinomas. Carcinomas with a labelling index higher than 2.3% were cribriform and undifferentiated carcinomas with marked nuclear anaplasia. The present studies have shown a correlation between both histological classification and cytological appearances with indicators of cell kinetics.U

Citing Articles

Grading of prostate cancer: a work in progress.

Kweldam C, van Leenders G, van der Kwast T Histopathology. 2018; 74(1):146-160.

PMID: 30565302 PMC: 7380027. DOI: 10.1111/his.13767.

[Prostate cancer. Part 1: Review of cell kinetics over the years 1966-2015 and future perspectives of the new grading of the International Society of Urological Pathology (ISUP)].

Helpap B, Bubendorf L Pathologe. 2016; 37(1):3-10.

PMID: 26792003 DOI: 10.1007/s00292-015-0123-y.

References

Faul P, SCHMIEDT E, Kern R . [The prognostic significance of cytologic differentiation grades of estrogen-treated prostata carcinoma. Progress control of 496 prostate carcinoma patients treated with estrogen for five years (author's transl)]. Urologe A. 1978; 17(6):377-81. View

Epstein N, Fatti L . Prostatic carcinoma: some morphological features affecting prognosis. Cancer. 1976; 37(5):2455-65. DOI: 10.1002/1097-0142(197605)37:5<2455::aid-cncr2820370539>3.0.co;2-v. View

Kastendieck H . [Ultrastructural Pathology of the human prostatic gland. Cyto- and histormophogenesis of atrophy, hyperplasia, metaplasia, dysplasia and carcinoma (author's transl)]. Veroff Pathol. 1977; (106):1-163. View

MELLINGER G, Gleason D, Bailar 3rd J . The histology and prognosis of prostatic cancer. J Urol. 1967; 97(2):331-7. DOI: 10.1016/S0022-5347(17)63039-8. View

Epstein N . Prostatic carcinoma. Correlation of histologic features of prognostic value with cytomorphology. Cancer. 1976; 38(5):2071-7. DOI: 10.1002/1097-0142(197611)38:5<2071::aid-cncr2820380532>3.0.co;2-7. View

Helpap B, Stiens R, Bruhl P . [Autoradiographic in vitro investigations on prostatic tissue with the C-14- und H-3-thymidine double-labeling method (author's transl)]. Beitr Pathol. 1974; 151(1):65-74. View

GLEASON D . Classification of prostatic carcinomas. Cancer Chemother Rep. 1966; 50(3):125-8. View

Epstein N . Prostatic biopsy. A morphologic correlation of aspiration cytology with needle biopsy histology. Cancer. 1976; 38(5):2078-87. DOI: 10.1002/1097-0142(197611)38:5<2078::aid-cncr2820380533>3.0.co;2-k. View

Helpap B, Stiens R, Bruhl P . The proliferative pattern of the prostatic carcinoma before and under hormonal treatment. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1976; 87(3):311-20. DOI: 10.1007/BF00506504. View

10.

Bocking A, Sinagowitz E, Thon W, Nattenmuller E, Wagner J, Sandritter W . [Histological staging of prostatic carcinoma]. Med Welt. 1979; 30(8):275-9. View

11.

Esposti P . Cytologic malignancy grading of prostatic carcinoma by transrectal aspiration biopsy. A five-year follow-up study of 469 hormone-treated patients. Scand J Urol Nephrol. 1971; 5(3):199-209. DOI: 10.3109/00365597109133601. View

12.

RABES H, Faul P . [Determination of proliferative activity of human prostatic needle biopsies by means of 3H-thymidine autoradiography (author's transl)]. Verh Dtsch Ges Pathol. 1973; 57:318-22. View

13.

SCHUBERT G, Ziegler H, Volter D . [Comparison of histological and cytological studies of the prostate with special reference to oestrogene induced changes (author's transl)]. Verh Dtsch Ges Pathol. 1973; 57:315-8. View

14.

Helpap B, Otten J . [Histologic-cytologic grading of uniform and pluriform prostate cancers]. Pathologe. 1982; 3(4):216-22. View

15.

Kastendieck H . [Morphology of prostate carcinoma in biopsies and total prostatectomies. Relevance of biopsy findings]. Pathologe. 1980; 2(1):31-43. View

16.

ALKEN C, Dhom G, Kopper D, Rehker H, Dietz R, Kopp S . [Prostate carcinoma: determination of progression following high-voltage therapy (author's transl)]. Urologe A. 1977; 16(5):272-8. View

17.

GLEASON D, MELLINGER G . Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol. 1974; 111(1):58-64. DOI: 10.1016/s0022-5347(17)59889-4. View

18.

Murphy G, WHITMORE Jr W . A report of the workshops on the current status of the histologic grading of prostate cancer. Cancer. 1979; 44(4):1490-4. DOI: 10.1002/1097-0142(197910)44:4<1490::aid-cncr2820440444>3.0.co;2-0. View

19.

ALKEN C, Dhom G, Straube W, Braun J, Kopper B, Rehker H . [Therapy of the carcinoma of the prostate and case control (III) (Author's transl)]. Urologe A. 1975; 14(3):112-6. View

20.

Mostofi F . Grading of prostatic carcinoma. Cancer Chemother Rep. 1975; 59(1):111-7. View